Teachers Retirement System of The State of Kentucky decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 30.8% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 260,194 shares of the company's stock after selling 115,614 shares during the period. Teachers Retirement System of The State of Kentucky owned about 0.16% of Option Care Health worth $9,094,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health during the fourth quarter valued at $26,000. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC raised its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after purchasing an additional 332 shares during the last quarter. Finally, Johnson Financial Group Inc. purchased a new position in Option Care Health during the fourth quarter valued at approximately $47,000. Hedge funds and other institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on OPCH. JMP Securities restated a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Wednesday, June 18th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. Finally, Barrington Research reissued an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and an average price target of $35.50.
Read Our Latest Stock Analysis on OPCH
Option Care Health Price Performance
Shares of OPCH traded down $0.57 during mid-day trading on Thursday, hitting $29.57. The company's stock had a trading volume of 302,504 shares, compared to its average volume of 1,840,747. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The firm has a 50-day simple moving average of $31.45 and a 200 day simple moving average of $31.75. The firm has a market capitalization of $4.84 billion, a P/E ratio of 23.85, a P/E/G ratio of 1.93 and a beta of 0.73. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. Option Care Health's revenue was up 16.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.26 earnings per share. Analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.